EC Number |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
---|
2.3.1.39 | Breast Neoplasms |
29751678 |
(-)-Epigallocatechin 3-Gallate Synthetic Analogues Inhibit Fatty Acid Synthase and Show Anticancer Activity in Triple Negative Breast Cancer. |
causal interaction therapeutic application unassigned |
1 1 0 |
2.3.1.39 | Carcinoma |
29751678 |
(-)-Epigallocatechin 3-Gallate Synthetic Analogues Inhibit Fatty Acid Synthase and Show Anticancer Activity in Triple Negative Breast Cancer. |
causal interaction therapeutic application unassigned |
1 1 0 |
2.3.1.39 | Triple Negative Breast Neoplasms |
29751678 |
(-)-Epigallocatechin 3-Gallate Synthetic Analogues Inhibit Fatty Acid Synthase and Show Anticancer Activity in Triple Negative Breast Cancer. |
causal interaction therapeutic application unassigned |
1 1 0 |
2.3.1.39 | Neoplasms |
27343380 |
(S)YS-51, a novel isoquinoline alkaloid, attenuates obesity-associated non-alcoholic fatty liver disease in mice by suppressing lipogenesis, inflammation and coagulation. |
causal interaction unassigned |
3 0 |
2.3.1.39 | Breast Neoplasms |
27291048 |
1, 3, 6-Trihydroxy-7-methyl-9, 10-anthracenedione isolated from genus Lindera with anti-cancer activity. |
causal interaction ongoing research therapeutic application unassigned |
3 2 4 0 |
2.3.1.39 | Neoplasms |
27291048 |
1, 3, 6-Trihydroxy-7-methyl-9, 10-anthracenedione isolated from genus Lindera with anti-cancer activity. |
causal interaction ongoing research therapeutic application unassigned |
3 2 4 0 |
2.3.1.39 | Carcinoma |
18199615 |
1-11C-acetate as a PET radiopharmaceutical for imaging fatty acid synthase expression in prostate cancer. |
causal interaction diagnostic usage ongoing research therapeutic application |
4 4 4 2 |
2.3.1.39 | Neoplasms |
18199615 |
1-11C-acetate as a PET radiopharmaceutical for imaging fatty acid synthase expression in prostate cancer. |
causal interaction diagnostic usage ongoing research therapeutic application |
4 4 4 2 |
2.3.1.39 | Prostatic Neoplasms |
18199615 |
1-11C-acetate as a PET radiopharmaceutical for imaging fatty acid synthase expression in prostate cancer. |
causal interaction diagnostic usage ongoing research therapeutic application |
4 4 4 2 |
2.3.1.39 | Neuroblastoma |
20053345 |
24S-hydroxycholesterol effects on lipid metabolism genes are modeled in traumatic brain injury. |
ongoing research unassigned |
1 0 |